AIM-Bio launches website and hosts 1st symposium
Published November 24, 2020
AIM-Bio — a five-year, $27 million collaborative project between NC State, BTEC, and the Technical University of Denmark — recently achieved two milestones, according to Program Manager Delia Bradley. The AIM-Bio website is now live, and the first Biopharmaceutical Manufacturing Symposium successfully concluded Nov. 13.
The AIM-Bio website provides a comprehensive overview of the project, which officially began Jan. 1, 2020, and is funded by the Novo Nordisk Foundation. Created to establish an international collaborative research and training program in biomanufacturing science and technology, AIM-Bio focuses on products and technologies for the future of biopharmaceutical manufacturing. The project features programs involving research, professional development, international collaboration and exchange, and related initiatives.
AIM-Bio's first Biopharmaceutical Manufacturing Symposium was held online Nov. 12–13. In addition to faculty and staff from both NC State and the Technical University of Denmark, symposium participants included members of the AIM-Bio External Advisory Board and the Novo Nordisk Foundation. Highlights of the event included:
- An overview of the Novo Nordisk Foundation by Henning Jørgensen, Senior Scientific Manager;
- A presentation on Continuous Integrated Biomanufacturing: Towards Digital Twins and Process Control by Dr. Alois Jungbauer, Head, Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna; and
- A presentation on Continuous Fermentation and Production of Oral Semaglutide by John Glisson, Director of Fermentation at Novo Nordisk Pharmaceutical Industries, LP.
In addition, the symposium included sessions that highlighted the AIM-Bio research projects, lifelong learning program, and the international exchange program. Plans call for the event to be held annually.